SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-048056
Filing Date
2014-08-08
Accepted
2014-08-08 16:03:14
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT v385154_10q.htm 10-Q 353345
2 EXHIBIT 31.1 v385154_ex31-1.htm EX-31.1 10331
3 EXHIBIT 31.2 v385154_ex31-2.htm EX-31.2 10534
4 EXHIBIT 32.1 v385154_ex32-1.htm EX-32.1 4502
  Complete submission text file 0001144204-14-048056.txt   2913195

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mtnb-20140630.xml EX-101.INS 325930
6 XBRL TAXONOMY EXTENSION SCHEMA mtnb-20140630.xsd EX-101.SCH 38408
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtnb-20140630_cal.xml EX-101.CAL 21913
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtnb-20140630_def.xml EX-101.DEF 185389
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtnb-20140630_lab.xml EX-101.LAB 192905
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtnb-20140630_pre.xml EX-101.PRE 213699
Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Filer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-193455 | Film No.: 141027480
SIC: 2834 Pharmaceutical Preparations